As per our report, the global dermal fillers market size is expected to grow at 6.67% CAGR during the forecast period. Dermal filler is a soft tissue filler which helps to repair the skin by filling the underlying tissues. These dermal fillers are also called as injectable implants and wrinkle fillers. There are two types of’ dermal fillers, which are absorbable and non-absorbable. These are manufactured from sugar molecules and compounds like hyaluronic acids and collagens.
The dermal filler technique is cost-efficient compare to surgical procedures available in the market. Dermal filler has applications other than ageing such as HIV induced facial lipoatrophy, in the treatment of paralyzed vocal cords, enhancement of the dorsal area of the hand.
The growing geriatric population will behave as a rendering factor of high impact for the expansion of the industry. Increasing numbers of older people undergoing dermal filler therapy should increase business growth to restore lost volume and elevate sagging skin. According to WHO, there will be 1.5 billion people above 60 in 2050.
The key market players are working on new and more advance technique to improve the treatment and to expand the product portfolio as the treatment last just for 6 to 12 months which is expected to drive the dermal filler market growth. There is an increasing demand for youth, and aesthetic facial skin is one of the drivers of the market.
With growing awareness of cosmetic anti-ageing processes and the rise in the prevalence of minimally invasive surgeries throughout the forecast period, the market is expected to grow lucratively. Moreover, the emergence of technologically advanced and user-friendly products coupled with other factors such as increasing social acceptance for aesthetic products, and the expansion strategies of market players in emerging countries are expected to drive market growth over the coming years.
However, the cost of dermal fillers is very high. This factor is leading to the online black market purchase in China, which is approximately to be 2/3 of the actual Chinese market size. No dermal filler rules and regulations in countries such as the United Kingdom, Brazil and other countries are restricting the market growth.
Market Size Available
2019 to 2025
2020 to 2025
By Product, Therapeutic Area and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
This market research report on Global Dermal Fillers Market has been segmented and sub-segmented based on the product, therapeutic area and region.
Dermal Fillers Market - By Product:
Based on product, the biodegradable fillers segment had the largest market share of about 82% in 2019 and predicted, it will continue the same trend in the coming years. It is due to the porous assets. The rise in the demand to improve the quality of the treatment procedures is escalating market growth.
The non-biodegradable segment is estimated to present a CAGR of 9.2% from 2019 to 2024. These non-absorbable fillers outcomes can be seen for a period of 6-24months. The market postulate for non-absorbable will show sufficient growth in the forthcoming years.
Dermal Fillers Market Analysis - By Therapeutic Area:
Based on the therapeutic area, in 2019, the deep facial lines, wrinkles are the leading segments in the market. These two segments are projected to grow at a healthy rate during the forecast period. Growing older people population across the globe and increasing demand for cosmetic surgeries are propelling the need of the market. Also, the adoption of a sedentary lifestyle and changes in food habits are surging the growth of the market.
Dermal Fillers Market Analysis - By Region:
Regionally, North America accounted for the largest share in the global dermal filler market in 2019. The increasing demand for non- invasive procedure is boosting the market growth. The need for the less complex, pain and the long-lasting process is driving the market in the North American market. The dermal filler comes under the U.S. FDA which has reduced the risk factor related with overuse of chemicals, this has increased the awareness about the advantage of the dermal fillers, and this will propel growth rate of the dermal filler market. There is an increasing number of aged people in this region due to the excellent mortality rate, and the low cost of the procedure is boosting the market growth in this region.
The European area has the second-largest share in the global dermal filler market. Rising geriatric population in this region is promoting the growth of the market. The more advance technique and the ongoing clinical trial is propelling the market growth in this region. The increasing geriatric rate and availability of procedure at low cost, there are 140 fillers in the market which is escalating the market. The fillers are non- prescription medicine in Europe which is another major factor leading to the growth of the market.
TOP COMPANIES IN THE MARKET
Companies like Allergan Inc., AQTIS Medical, Bioha Laboratories, Suneva Medical, Galderma, Merz Aesthetics, Cynosure, Syneron and Cytophil Inc. are playing a leading role in the global dermal fillers market.
RECENT MARKET DEVELOPMENTS
On May 05 2020, the US FDA has approved Galderma for the launch of Restylane Kysse for lip augmentation and correction of upper perioral rhytids in adults over the age of 21.
Merz launches new Belotero Revive dermal filler. It is a combination of hyaluronic acid and glycerol design which improves the hydration and firmness of the skin.
On February 26, 2020, BioScience GmbH has launched a new line of injectable. The range contains two product such as Hyaprof soft and Hyaprof balance.
On January 10, 2020, Revance Therapeutics signed a distribution agreement with TEOXANE SA for the distribution of a range of dermal filler, there innovative Resilient Hyaluronic Acid contains products like RHA2, RHA3 and RHA4.
On April 09, 2018, Merz Aesthetics launched Belotero Lips, specifically designed to treat perioral lines effectively and safely.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Absorbable or Biodegradable
5.1.3 Non-Absorbable or Non-Biodegradable
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.3 Deep Facial Lines
5.2.4 Sagging Skin
5.2.6 Y-o-Y Growth Analysis, By Therapeutic Area
5.2.7 Market Attractiveness Analysis, By Therapeutic Area
5.2.8 Market Share Analysis, By Therapeutic Area
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Therapeutic Area
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Therapeutic Area
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Allergan Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AQTIS Medical
8.3 Bioha Laboratories
8.4 Suneva Medical
8.6 Merz Aesthetics
8.9 Cytophil Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures